Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
28.85
+2.09 (7.81%)
Aug 26, 2026, 4:00 PM EDT - Market closed

Cue Biopharma Revenue

Cue Biopharma had revenue of $7.88M in the quarter ending June 30, 2026, with 166.66% growth. This brings the company's revenue in the last twelve months to $37.65M, up 354.37% year-over-year. In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth.

Revenue (ttm)
$37.65M
Revenue Growth
+354.37%
P/S Ratio
5.57
Revenue / Employee
$1,298,448
Employees
29
Market Cap
209.58M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.47M18.18M195.75%
Dec 31, 20249.29M3.80M69.16%
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.01K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Codexis77.68M
MediWound11.86M
Caribou Biosciences10.04M
Humacyte2.12M
Molecular Partners AG856.30K
Spruce Biosciences697.00K
Revenue Rankings